Population Pharmacokinetic Analysis of Tucatinib in Healthy Participants and Patients with Breast Cancer or Colorectal Cancer
Authors
- Ariel R. Topletz‐Erickson (ORCID: https://orcid.org/0000-0002-8909-4685)
- Daping Zhang (ORCID: https://orcid.org/0009-0000-1646-094X)
- Christopher J. Endres (ORCID: https://orcid.org/0009-0000-5827-0482)
- Jie Zhao (ORCID: https://orcid.org/0000-0002-7878-9801)
- Adekemi B. Taylor (ORCID: https://orcid.org/0000-0002-7373-5660)
Institutions
- Pfizer (United States) (US)
- Immunome (United States) (US)
- Certara (United States) (US)
Publication Details
- Journal
- Clinical Pharmacokinetics
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1007/s40262-024-01412-0
- Citations
- 2
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.57